Without the generous support of our friends, ADI would not be able to carry out the meaningful work that it does.
Below is a list of our corporate partners, contributors and funders, including trusts, foundations, corporations and individuals that support us.
ADI is also grateful for the continuing support of all of our member Alzheimer associations through their annual membership dues.
Gold partners
Silver partners
Bronze partners
Website
We are grateful to the Mary Oakley Foundation for supporting the development of this website.
Donors and contributors
Industry
- AbbVie
- Acumen Pharmaceuticals
- AC Immune
- ACADIA Pharmaceuticals
- Alector
- Biogen
- Bristol Myers Squibb
- Care UK
- C2N Diagnostics
- Eisai
- Eli Lilly
- GE Healthcare
- GT Diagnostics
- Home Instead
- IFPMA
- Life Molecular Imaging
- Lundbeck
- MSD
- Novartis International AG
- Novo Nordisk
- Nutricia Advanced Medical Nutrition
- Otsuka
- Parexel
- PhRMA
- Phastar
- Prothena
- Re:Cognition Health
- Roche
- Tunstall
Non-industry
- Alzheimer’s Disease International member dues
- Helen Daniels Bader Fund, A Bader Philanthropy
- Iris Harvey
- JD Power
- London School of Economics (LSE)
- Mary Oakley Foundation
- Diane and Dan Riccio
- Skylight Frame
- STEP
- ZiMAD
- de Mol van Otterloo Family
Alzheimer’s Disease International funding is derived from 39:61, industry vs non-industry funding. The largest funder provides 7% of overall income. ADI does not receive funding from Governments.
ADI’s audited accounts are publicly available online